AstraZeneca plc buy phonebroker
Start price
18.12.20
/
50%
€83.36
Target price
€90.00
Performance (%)
-3.42%
End price
11.03.21
€80.51
Summary
This prediction ended on 11.03.21 with a price of €80.51. With a performance of -3.42%, the BUY prediction for AstraZeneca plc by phonebroker closed slightly in the red. A total of €1.59 was paid as dividends for this prediction. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| AstraZeneca plc | -0.620% | -0.620% | -6.252% | 51.358% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
According to phonebroker what are the pros and cons of AstraZeneca plc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Higher risks for its business
Comments by phonebroker for this prediction
In the thread AstraZeneca plc diskutieren
Buy AstraZeneca plc
Hoffentlich ist das Impfprodukt besser als die Kursentwicklung.
Hoffentlich ist das Impfprodukt besser als die Kursentwicklung.